| 000 | 01339 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250516161555.0 | ||
| 264 | 0 | _c20140610 | |
| 008 | 201406s 0 0 eng d | ||
| 022 | _a1179-1926 | ||
| 024 | 7 |
_a10.1007/s40262-013-0099-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOpdam, Frans L | |
| 245 | 0 | 0 |
_aBreath tests to phenotype drug disposition in oncology. _h[electronic resource] |
| 260 |
_bClinical pharmacokinetics _cNov 2013 |
||
| 300 |
_a919-26 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_a2-Pyridinylmethylsulfinylbenzimidazoles _xpharmacokinetics |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aBreath Tests |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xgenetics |
| 650 | 0 | 4 |
_aDextromethorphan _xpharmacokinetics |
| 650 | 0 | 4 |
_aDihydrouracil Dehydrogenase (NADP) _xgenetics |
| 650 | 0 | 4 |
_aErythromycin _xpharmacokinetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aPantoprazole |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aUracil _xpharmacokinetics |
| 700 | 1 | _aModak, Anil S | |
| 700 | 1 | _aGelderblom, Hans | |
| 700 | 1 | _aGuchelaar, Henk-Jan | |
| 773 | 0 |
_tClinical pharmacokinetics _gvol. 52 _gno. 11 _gp. 919-26 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s40262-013-0099-9 _zAvailable from publisher's website |
| 999 |
_c22930464 _d22930464 |
||